Core A: Administrative Core
核心A:行政核心
基本信息
- 批准号:8676141
- 负责人:
- 金额:$ 66.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-01 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdvertisingAgingAlzheimer&aposs DiseaseAreaBasic ScienceBiological MarkersBiologyBiomedical ResearchC9ORF72ClinicalClinical ResearchClinical TrialsCollaborationsCommunity HealthcareComplexDataDementiaDevelopmentDifferential DiagnosisDiseaseEarly InterventionEducationEnsureEnvironmentGeneticGoalsHealthHealthcareHuman ResourcesInstitutesInstitutionInterventionLeadershipLewy Body DementiaMedical centerMentorsMissionMonitorNerve DegenerationOffice of Administrative ManagementParkinson DiseaseParkinson&aposs DementiaPathologyPathway interactionsPatientsPhenotypePhysiciansPreventionPrevention strategyProductivityRegenerative MedicineRegulationResearchResearch InstituteResearch PersonnelResearch PriorityResearch Project GrantsResearch SubjectsResourcesRoleRunningStagingSupport GroupsTNFRSF5 geneTraining SupportTranslatingTranslational ResearchUnited States National Institutes of HealthUniversitiesUpdateabstractingalpha synucleincommunity organizationsimprovedinterestmeetingsmild cognitive impairmentneuropsychologicalnovelpre-clinicalprogramsresearch studysoundweb site
项目摘要
CORE A: ADMINISTRATIVE - ABSTRACT
The UCSD Alzheimer's Disease Research Center (ADRC) has contributed greatly to research progress in
the past 30 years. Strong administrative management of the Center will be maintained during the renewal to
set goals and direction, maintain a supportive environment for investigators, manage Cores, projects and
personnel, and interact with University Administration, NIH, and researchers at other Centers. The ADRC
will emphasize 3 research themes: 1) detailed phenotyping of early stages of AD, including Mild Cognitive
Impairment (MCI) and preclinical AD; 2) research into non-AD dementias; 3) Basic studies of
neurodegeneration in AD and related disorders, emphasizing translational research.
Specific Aims of the Administrative Core include:
1) Provide overall scientific leadership to the ADRC and advance its mission, ensuring that resources are
available. 2) Oversee and support Cores and Projects of the ADRC. 3) Build synergy and collaborations
with clinicians and researchers at UCSD and VA Medical Center. 4) Continue and strengthen collaboration
with researchers at other outstanding biomedical research institutions in San Diego. 5) Partner with
community organizations and health care networks to advance education and enhance recruitment. This
includes the Alzheimer Association and other patient organizations, and physicians at large San Diego
HMOs. 6) Solicit Pilot research projects each year, arrange for review and submission to NIA. 7) Provide
sound fiscal management for the Center. 8) Communicate and meet annually with our External Advisory
Board. 9) Interact with other ADCs, NACC and ADCS to support multi-ADC projects and initiatives,
including clinical trials. 10) Liaise with NIA and NACC and attend semi-annual national AD Center meetings.
11) Ensure that ADRC staff are knowledgeable about and comply with regulations. 12) Maintain a detailed
and updated website to highlight ADRC research, for the public and researchers.
核心A:行政-摘要
加州大学圣地亚哥分校阿尔茨海默病研究中心(ADRC)为以下方面的研究进展做出了巨大贡献:
过去30年在更新期间,中心将保持强有力的行政管理,
设定目标和方向,为研究者维持一个支持性的环境,管理核心、项目和
人员,并与大学管理,NIH和其他中心的研究人员互动。自抗扰控制
将强调3个研究主题:1)AD早期阶段的详细表型,包括轻度认知障碍
损害(MCI)和临床前AD; 2)对非AD痴呆的研究; 3)
AD和相关疾病中的神经变性,强调转化研究。
行政核心的具体目标包括:
1)为ADRC提供全面的科学领导,推进其使命,确保资源
available. 2)监督和支持ADRC的核心和项目。3)建立协同作用和协作
加州大学圣地亚哥分校和退伍军人医疗中心的临床医生和研究人员。4)继续并加强合作
与圣地亚哥其他优秀生物医学研究机构的研究人员一起工作。5)伙伴
社区组织和保健网络,以促进教育和加强招聘。这
包括阿尔茨海默病协会和其他患者组织,以及圣地亚哥的医生
健康维护组织6)每年征集试点研究项目,安排评审并提交国家创新局。7)提供
为中心提供良好的财务管理。8)每年与我们的外部顾问进行沟通和会面
纸板. 9)与其他ADC、NACC和ADCS互动,以支持多ADC项目和倡议,
包括临床试验。10)与NIA和NACC保持联络,并参加半年度的国家AD中心会议。
11)确保ADRC员工了解并遵守法规。12)保持详细的
并更新网站,突出ADRC的研究,为公众和研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOUGLAS R GALASKO其他文献
DOUGLAS R GALASKO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOUGLAS R GALASKO', 18)}}的其他基金
A Single Ascending Dose / Multiple Ascending Dose Phase I study of the GSM 776890 in healthy normal subjects
健康正常受试者中 GSM 776890 的单次递增剂量/多次递增剂量 I 期研究
- 批准号:
10335246 - 财政年份:2021
- 资助金额:
$ 66.81万 - 项目类别:
Comparative Study of Molecular Signatures in HIV-Related Neuropathogenesis and Alzheimer's Disease
HIV 相关神经发病机制和阿尔茨海默氏病分子特征的比较研究
- 批准号:
10407966 - 财政年份:2018
- 资助金额:
$ 66.81万 - 项目类别:
Comparative Study of Molecular Signatures in HIV-Related Neuropathogenesis and Alzheimer's Disease
HIV 相关神经发病机制和阿尔茨海默氏病分子特征的比较研究
- 批准号:
10153614 - 财政年份:2018
- 资助金额:
$ 66.81万 - 项目类别:
Translational Center for Alzheimer's Disease Target and Drug Discovery
阿尔茨海默病靶点和药物发现转化中心
- 批准号:
8849662 - 财政年份:2014
- 资助金额:
$ 66.81万 - 项目类别:
A TRIAL OF TTP488 TO SLOW THE RATE OF CLINICAL PROGRESSION OF PATIENTS WITH AD
TTP488 减缓 AD 患者临床进展速度的试验
- 批准号:
7197191 - 财政年份:2006
- 资助金额:
$ 66.81万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 66.81万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 66.81万 - 项目类别:
Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 66.81万 - 项目类别:
Collaborative R&D
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 66.81万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 66.81万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 66.81万 - 项目类别:
Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 66.81万 - 项目类别:
Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 66.81万 - 项目类别:
Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
- 批准号:
498278 - 财政年份:2024
- 资助金额:
$ 66.81万 - 项目类别:
Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
- 批准号:
24K04938 - 财政年份:2024
- 资助金额:
$ 66.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)